Elequin Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Elequin Capital's JAZZ Position: Q2 2026 in Review
Elequin Capital sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 127 shares — an estimated $24K sold.
Elequin Capital first reported a position in JAZZ in Q1 2022 and held it in 9 quarters. The position peaked at $47K in Q2 2022. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Elequin Capital reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Elequin Capital sold 127 Jazz Pharmaceuticals shares in Q2 2026, an estimated $24K.
- Elequin Capital first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 9 quarters.
- Elequin Capital's Jazz Pharmaceuticals position peaked at $47K in Q2 2022.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.